Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Oct 2026, 2:00 pmDue tomorrow
Published by the portal on this tender, for queries and grievance redressal.
Drugs and
9932444
GEM/2026/B/8071043
Two Packet Bid
Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Bardhaman, West Bengal
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹10 L
₹50 L
30%
Exempted
Yes
28 Sept 2026
28 Sept 2026
9 Oct 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Tab Acarbose 25 mg | 12,400 | No | OICMSTORES | 30 |
| 2 | Title2 | Tab Trifluridine 20+ Tipiracil 8.19mg | 90 | No | OICMSTORES | 30 |
| 3 | Title3 | Inj Bortezomib 2mg | 12 | Vial | OICMSTORES | 30 |
| 4 | Title4 | Inj Zoledronic acid 5 mg | 15 | PFS | OICMSTORES | 30 |
| 5 | Title5 | Inj Influenza vaccine (Quadrivalent) | 70 | PFS | OICMSTORES | 30 |
| 6 | Title6 | Inj Erythropoeitin recombinant human 2000 IU | 200 | PFS | OICMSTORES | 30 |
| 7 | Title7 | Inj Erythropoietin recombinant human 4000 IU | 90 | PFS | OICMSTORES | 30 |
| 8 | Title8 | Inj Erythropoietin recombinant human 5000 IU | 60 | PFS | OICMSTORES | 30 |
| 9 | Title9 | Inj Erythropoietin recombinant human 6000 IU | 180 | PFS | OICMSTORES | 30 |
| 10 | Title10 | Tab Acebrophylline 200mg SR | 1,200 | No | OICMSTORES | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9932444.pdf
GEM_BID • 1.02 MB
echs_boq_6_2026-09-23-09-04-59_61f79fde5c4c7f3b4b0ac114db8c36f9.pdf
BOQ • 0.20 MB
echs_boq_2026-09-23-09-04-59_e64e57d333c782c59ce7bfcac7a0ae03.csv
BOQ • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .